KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Edwards Lifesciences (EW) Non-Current Receivables (2016)

Edwards Lifesciences has reported Non-Current Receivables over the past 6 years, most recently at $5.3 million for Q3 2016.

  • For Q3 2016, Non-Current Receivables fell 3.64% year-over-year to $5.3 million; the TTM value through Sep 2016 reached $5.3 million, down 3.64%, while the annual FY2015 figure was $3.6 million, 37.93% down from the prior year.
  • Non-Current Receivables for Q3 2016 was $5.3 million at Edwards Lifesciences, roughly flat from $5.3 million in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $21.4 million in Q1 2012 and troughed at $3.6 million in Q4 2015.
  • A 5-year average of $8.4 million and a median of $7.3 million in 2013 define the central range for Non-Current Receivables.
  • Biggest five-year swings in Non-Current Receivables: plummeted 59.76% in 2012 and later increased 19.27% in 2013.
  • Year by year, Non-Current Receivables stood at $9.9 million in 2012, then fell by 26.26% to $7.3 million in 2013, then fell by 20.55% to $5.8 million in 2014, then plummeted by 37.93% to $3.6 million in 2015, then surged by 47.22% to $5.3 million in 2016.
  • Business Quant data shows Non-Current Receivables for EW at $5.3 million in Q3 2016, $5.3 million in Q2 2016, and $5.8 million in Q1 2016.